跳至主要内容
临床试验/JPRN-jRCTs041180034
JPRN-jRCTs041180034已完成2 期

ithium for mild-to-moderate Alzheimer's disease: A randomized double-blind, placebo-controlled study

Iwata Nakao0 个研究点目标入组 46 人开始时间: 2019年1月29日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
46

研究概览

简要总结

The results of this study showed that lithium was not effective for Alzheimer's disease. In terms of safety, lithium did not show a statistically significant difference in the placebo group. The main limitation of the study is the lack of power due to failure to reach the target number of cases.

研究设计

研究类型
Interventional

入排标准

年龄范围
none 至 none(—)
性别
All

入选标准

  • (1) The patient meets Diagnostic and Statistical Manual of Mental Disorders-V probable Alzheimer's disease.
  • (2) Clinical Dementia Rating scores are 1 or 2 points.

排除标准

  • (1)Patients complicated of dementia other than Alzheimer's disease.
  • (2)Patients with a history of drug hypersensitivity to lithium.
  • (3)Lithium carbonate administration is contraindicated.
  • (4)Patients with severe complications and poor management.
  • (5)Patients with renal dysfunction (creatinine clearance <30).

研究者

发起方
Iwata Nakao

相似试验